Skip to main content

IGM Biosciences, Inc.

IGMSDelisted Aug 14, 2025
Industry
Pharmaceutical Preparations
SEC CIK
0001496323

IGM Biosciences, Inc. was delisted on Aug 14, 2025; its insiders filed their last Form 4 on Aug 18, 2025; 66 institutions reported holding it in 13F filings for Q2 2025, worth $17.9M in total; no superinvestor held it.

Q2 2023 vs. Q1 2023

How the institutions holding IGM Biosciences, Inc. changed between Q1 2023 and Q2 2023.

All holders in Q2 2023All holders in Q1 2023

13F holders of IGMS: Q1 2023 compared with Q2 2023
MeasureQ1 2023Q2 2023Change
Holders7579+4
Shares17.9M22.3M+4.41M (+24.7%)
Value$245.4M$207.6M−$37.8M (−15.4%)

New holders (20)

Institutions that held IGM Biosciences, Inc. at the end of Q2 2023 but not at the end of Q1 2023.

Institutions new to IGMS in Q2 2023
InstitutionSharesValue% of portfolio
Ra Capital Management, L.P.937,500$8.65M0.16%
Great Point Partners LLC500,000$4.62M0.92%
Jacobs Levy Equity Management, Inc137,575$1.27M0.01%
Walleye Capital LLC69,417$640.7K0.01%
Opaleye Management Inc.63,500$586.1K0.14%
Moore Capital Management, LP50,000$461.5K0.01%
Susquehanna International Group, LLP41,941$387.1K0.00%
Squarepoint Ops LLC26,312$242.9K0.00%
Maven Securities LTD24,800$228.9K0.03%
Trexquant Investment LP23,387$215.9K0.01%
Jump Financial, LLC19,783$182.6K0.01%
Prelude Capital Management, LLC19,675$181.6K0.02%
Verition Fund Management LLC17,306$159.7K0.00%
HRT Financial LP15,257$140.0K0.00%
Engineers Gate Manager LP14,734$136.0K0.01%
Exchange Traded Concepts, LLC13,800$127.4K0.00%
Prudential Financial Inc12,070$111.4K0.00%
Lazard Asset Management LLC2,894$26.0K0.00%
Endurance Wealth Management, Inc.300$3.00K0.00%
Toronto Dominion Bank34$00.00%

Sold out (16)

Institutions that held IGM Biosciences, Inc. at the end of Q1 2023 and filed for Q2 2023 without it.